Clinical Trials · NCT02685709

Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly

Name: Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Octreotide Lanreotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Chiasma, Inc.
Enrollment: 146
Start date: Feb 2016
Locations: 53 sites, 13 countries
Primary endpoint: Proportion of Patients Who Are Biochemically Controlled Throughout the RCT Phase

View Octreotide compound reference